170442 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines; Interferons [IFN] IFN-gamma
MYCOBACTERIUM TUBERCULOSIS PROTEINS IN DIAGNOSTIC ASSAYS AND DEVICES FOR TUBERCULOSIS DETECTION AND DIAGNOSIS
#2METHOD OF TREATMENT OF HIV INFECTION WITH VACCINE
#3PEPTIDES WITH CYTOKINE-RELEASING ACTIVITY AND METHODS FOR CHARACTERIZING CYTOKINE-RELEASING PROFILES OF PEPTIDES
#4COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS AND ANTI-PD-1 ANTIBODIES
#5COMPOSITIONS AND METHODS FOR ANALYSIS, DETECTION, AND TREATMENT OF MULTIPLE SCLEROSIS
#6DEXAMETHASONE FOR TREATING AUTISM
#7MICROBIAL METABOLITES ON INTESTINAL INFLAMMATION
#8CELL MEDIATED IMMUNE RESPONSE ASSAY
#9MOUSE MODELS OF CYTOKINE RELEASE SYNDROME
#10IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY
#11USE OF EMAPALUMAB FOR TREATMENT
#12IMMUNOASSAY FOR DETECTING BIOLOGICALLY ACTIVE PROTEINS
#13PHOSPHATIDYLSERINE TARGETING MOLECULE COMBINED WITH MEMORY T CELL ANTIGEN FOR THERAPEUTIC, DIAGNOSTIC AND ADJUVANT USE
#14COMBINATION ASSAY OF CYTOKINES AND HUMAN ANTIBODIES TO MAP FOR THE DIAGNOSIS OF CROHNS DISEASE, TUBERCULOSIS, AND OTHER BACTERIAL DISEASES
#15METHODS FOR PREDICTING EFFICACY OF A MODIFIED LIVE PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) VACCINE
#16FUNCTIONAL ASSAY FOR QUICKLY DETERMINING IMMUNE STATUS
#17METHOD FOR EVALUATING QUALITY OF INDUCEMENT INHIBITORY-T-CELL FORMULATION
#18BOOSTED IMMUNE MONITORING METHODS FOR ASSAYING ANTIGEN-SPECIFIC T CELL RESPONSES
#19USE OF AMINO ACID SEQUENCES FROM MYCOBACTERIUM TUBERCULOSIS OR CORRESPONDING NUCLEIC ACIDS FOR DIAGNOSIS AND PREVENTION OF TUBERCULAR INFECTION, DIAGNOSTIC KIT AND VACCINE THEREFROM
#20METHODS FOR TREATING BLADDER CANCER
#21MULTIPLEX CELLULAR ASSAYS FOR SCREENING AND QUALITY ASSESSMENT OF ENGINEERED CELLS
#22CRISPR/CAS-Associated Detection Assays, Methods and Kits
#23ANTI-PD1 THERAPY BASED ON RESPONSE TO IFN-I STIMULATION
#24EX VIVO MODEL OF INFLAMED HUMAN SKIN AND USES THEREOF FOR SCREENING ANTI-INFLAMMATORY COMPOUNDS
#25COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNITY, INCLUDING AUTOIMMUNITY ASSOCIATED WITH CANCER AND CANCER THERAPY
#26VAGUS NERVE STIMULATION PRE-SCREENING TEST
#27METHODS AND COMPOSITIONS FOR T-CELL COCULTURE POTENCY ASSAYS AND USE WITH CELL THERAPY PRODUCTS
#28METHODS OF ISOLATING OF TUMOR INFILTRATING LYMPHOCYTES AND USE THEREOF
#29METHOD FOR PREDICTING THE OFF-TARGET BINDING OF A PEPTIDE WHICH BINDS TO A TARGET PEPTIDE PRESENTED BY A MAJOR HISTOCOMPATIBILITY COMPLEX
#30NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE
#31Patient Profiling for Antigen-Specific Immunomodulatory Therapies
#32ANTIGENIC TRIPEPTIDES DERIVED FROM MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS S-TYPE STRAINS, DERIVATIVES AND USES THEREOF
#33ALPHA-V-BETA-8 INTEGRIN INHIBITORS AND USES THEREOF
#34MOLECULAR SIGNATURES OF LONG-TERM COVID-19 AND TREATMENT THEREOF
#35BATCH RELEASE ASSAY FOR PHARMACEUTICAL PRODUCTS RELATING TO T CELL THERAPIES
#36CELL POTENCY ASSAYS, PLATFORMS, AND METHODS OF USE
#37METHODS AND COMPOSITIONS FOR IPSC-DERIVED MICROGLIA
#38Diagnostic and Treatment of Chronic Pathologies Such as Lyme Disease
#39METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER
#40EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE
#41METHODS AND COMPOSITIONS FOR T-CELL COCULTURE POTENCY ASSAYS AND USE WITH CELL THERAPY PRODUCTS
#42CHIMERIC RECEPTOR POLYPEPTIDE AND METHODS OF ACTIVATION THEREOF
#43COMPOSITIONS AND METHODS FOR DIAGNOSING SARS-COV-2 (COVID-19) AND FOR MONITORING SARS-COV-2-SPECIFIC IMMUNOLOGICAL MEMORY
#44Methods of Determining Immune Response
#45METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#46Antigenic tripeptides derived from subsp. s-type strains, derivatives and uses thereof
#47METHODS AND KITS FOR DIAGNOSING MILD COGNITIVE IMPAIRMENT
#48METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#49HER3 PULSED DC1 THERAPY
#50METHODS AND COMPOSITIONS FOR T-CELL COCULTURE POTENCY ASSAYS AND USE WITH CELL THERAPY PRODUCTS
#51METHODS FOR THE TREATMENT OF CANCER
#52IN VITRO METHOD FOR DISCRIMINATING LATENT FROM ACTIVE TUBERCULOSIS
#53IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY
#54METHOD FOR TREATING ATOPIC DERMATITIS USING MONOCLONAL STEM CELLS
#55SELECTION OF T CELL RECEPTORS
#56COMPOSITIONS AND METHODS FOR ENHANCING MUCOSAL IMMUNITY
#57Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#58METHODS AND ASSAYS FOR IMMUNE PHENOTYPING
#59USE OF PERIPHERAL BLOOD PRO- AND ANTI-INFLAMMATORY CYTOKINE RATIOS AS MARKERS OF IMPLANTATION PRECEDING PREGNANCY
#60BIOMARKERS
#61Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for the treatment of cancer
#62Vagus nerve stimulation pre-screening test
#63BIOMARKER PANELS FOR ON-TREATMENT PREDICTION OF RESPONSE TO IMMUNO-ONCOLOGY DRUGS
#64Tuberculosis diagnosis method and apparatus therefor
#65Methods of Treating an Autoimmune Disease with a Human Interleukin-3 (IL-3)-Diphtheria Toxin Conjugate (DT-IL3)
#66COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#67SARS-COV-2 infection biomarkers and uses thereof
#68METHODS, KITS AND COMPOSITIONS FOR CHARACTERIZING AN ANTI-INFLAMMATORY RESPONSE OF A PRODUCT
#69Method, Systems, and a Kit for Detection, Diagnosis, Monitoring and Treatment of COVID-19
#70Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#71Encryption device and operation method thereof
#72DIAGNOSTIC BLOOD TEST FOR SARCOIDOSIS
#73Methods for determining concentration of low and high concentration proteins in a single sample
#74Method for predicting the off-target binding of a peptide which binds to a target peptide presented by a major histocompatibility complex
#75Methods of immunotherapy
#76METHOD FOR CONFIRMING PRDM14 EXPRESSION
#77EphA2 T-cell epitope agonists and uses therefore
#78METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#79Methods and kits for determining tuberculosis infection status
#80DROPLET ARRAYS FOR DETECTION AND QUANTIFICATION OF ANALYTES
#81METHOD FOR MEASURING SYSTEMIC CHRONIC INFLAMMAGING
#82IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOF
#83CANCER SERUM BIOMARKERS AND METHODS OF USE THEREOF
#84Method for preparing nanocomposite and label-free aptamer electrochemical sensor of gamma-interferon based on the nanocomposite
#85DIGITAL IMMUNOASSAY
#86Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#87Diagnosis and risk stratification of fungal infections
#88METHODS FOR DETECTING, ASSESSING SEVERITY AND TREATING MULTIPLE SCLEROSIS
#89Biomarkers related to organ function
#90Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment
#91Methods and materials for assessing and treating cancer
#92IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY
#93Betaretrovirus epitopes and related methods of use
#94DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER
#95DOSAGE OF A GLUTEN PEPTIDE COMPOSITION
#96Cell mediated immune response assay
#97Materials and methods for subjects at risk for viral reactivation
#98Non-human animals having a humanized programmed cell death 1 gene
#99COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#100Biomarker Panel For Diagnosing Cancer
#101COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#102Antigenic tripeptides derived from subsp. s-type strains, derivatives and uses thereof
#103METHOD FOR MANUFACTURING A MEASURING KIT AND METHOD FOR ACCELERATING AN ATTACHMENT OF AN ORGANIC MOLECULE TO A CARRIER
#104Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#105METHOD FOR TREATING EPSTEIN-BARR VIRUS - POSITIVE CANCER WITH IMMUNOTHERAPY
#106Multilayer nanowire complex and method of preparing the same
#107Insulin mimotopes and methods of using the same
#108MYCOBACTERIUM TUBERCULOSIS PROTEINS IN DIAGNOSTIC ASSAYS AND DEVICES FOR TUBERCULOSIS DETECTION AND DIAGNOSIS
#109METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#110Assay for detecting TH1 and TH2 cell populations
#111COMPOSITIONS AND METHODS RELATING TO C5L2
#112COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS
#113COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#114BIOMARKERS
#115Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy
#116CNS Antigen-Specific B Cell and Antibody Assays in Multiple Sclerosis
#117Vagus nerve stimulation pre-screening test
#118Early Diagnosis of Autoimmune and Inflammatory Disorders
#119Collapsible element pocket former
#120EPHA2 t-cell epitope agonists and uses therefore
#121Collapsible element pocket former
#122Method for diagnosing and treating fibromyalgia
#123Compositions useful in the diagnostic of latently infected
#124IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOF
#125Methods and kits for determining tuberculosis infection status
#126Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate
#127Methods for treating cancer using PS-targeting antibodies with immuno-oncology agents
#128IDENTIFICATION OF PATIENTS IN NEED OF PD-L-1 INHIBITOR COTHERAPY
#129METHOD FOR MANUFACTURING A MEASURING KIT AND METHOD FOR ACCELERATING AN ATTACHMENT OF AN ORGANIC MOLECULE TO A CARRIER
#130Digital immunoassay
#131Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats
#132Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#133BIOMARKERS FOR PREDICTING A RESPONSE TO AN IMMUNOMODULATING TREATMENT IN PATIENTS WITH INFLAMMATORY DISEASE
#134NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE
#135Diagnostic blood test for sarcoidosis
#136Autoantigens for diagnosis of rheumatoid arthritis
#137METHODS OF TREATING WITH TUMOR MEMBRANE VESICLE-BASED IMMUNOTHERAPY AND PREDICTING THERAPEUTIC RESPONSE THERETO
#138NOVEL DESIGN OF ENZYME-LINKED IMMUNOSORBENT ASSAY PLATES AND SYSTEMS AND METHODS OF USE THEREOF
#139PRE-SYMPTOMATIC DIAGNOSIS OF A VIRAL ILLNESS
#140Insulin mimotopes and methods of using the same
#141Biomarker panel for diagnosing cancer
#142Polymeric Fc proteins and methods of screening to alter their functional characteristics
#143Methods For Screening Therapeutic Compounds
#144Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient
#145Method for treating epstein-barr virus—positive cancer with immunotherapy
#146Engineered Dendritic Cells and Uses for the Treatment of Cancer
#147METHODS AND COMPOSITIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS
#148METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#149ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS
#150METHODS OF IDENTIFYING ANTIGENS FOR VACCINES
#151METHODS FOR MONITORING CD4+ T-HELPER TYPE 1 RESPONSE IN CANCER AND IMMUNE RESTORATION
#152Compositions useful in the diagnostic of latently infected
#153proteins
#154METHODS OF DIAGNOSIS AND TREATMENT OF CELIAC DISEASE IN CHILDREN
#155METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#156METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#157ELISPOT method having two filter systems
#158Human exhaled aerosol droplet biomarker system and method
#159Methods for treating medical conditions by anti-type 2 therapy
#160COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS
#161Epitope recognized by anti-interferon gamma autoantibodies in patients with disseminated mycobacterial infections and the application therefor
#162Early Diagnosis of Autoimmune and Inflammatory Disorders
#163Methods of diagnosing and treating tuberculosis
#164Assay for detecting Th1 and Th2 cell populations
#165METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILES
#166METHODS OF MEASURING ANTIGEN-SPECIFIC T CELLS
#167Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#168COMPOSITIONS COMPRISING GLUTEN PEPTIDES AND USES THEREOF
#169METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#170Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
#171Eye disease treatment agent, screening method therefor, and method for predicting rejection response associated with retinal pigment epithelial cell transplant
#172Polymer particles and uses thereof
#173Compositions and methods for modulating an immune response
#174EphA2 T-cell epitope agonists and uses therefore
#175Immune monitoring to predict and prevent infection
#176MATERIALS AND METHODS FOR THE TREATMENT OF CELIAC DISEASE
#177METHODS OF T CELL EPITOPE PROFILING, MAKING T CELL COMPOSITIONS, AND TREATING DISEASES
#178Method for determining site having N-linked sugar chain added thereto or proportion of said addition
#179Interferon-gamma release assays for diagnosis of invasive fungal infections
#180Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors
#181CONDUCTIVE HYDROGELS FOR AFFINITY SENSING
#182METHODS FOR DIAGNOSING, SCREENING, IDENTIFYING, MONITORING, AND TREATING ADVERSE LOCAL TISSUE REACTIONS, WHICH LEAD TO FAILURE OF ORTHOPEDIC IMPLANTS
#183COMPOSITIONS AND METHODS RELATING TO C5L2
#184METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#185Biomarkers for Tuberculosis
#186Biomarkers related to organ function
#187Activities of multiple cancer-related pathways are associated with BRAF mutation and predict the resistance to BRAF/MEK inhibitors in melanoma cells
#188Dosage of a gluten peptide composition
#189Methods and kits for determining tuberculosis infection status
#190Suppression of cytokine release and cytokine storm
#191Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#192Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#193Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
#194Diagnostic blood test for sarcoidosis
#195Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment
#196Carbohydrate Compounds for Nutritional and Therapeutic Use
#197Glatiramer acetate human monocytic cell line-based potency assay
#198Methods for stimulating antigen-specific T cell responses
#199Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#200Parasitic biological agents for treatment and prevention of graft versus host disease
#201PLACEBO-CONTROLLED GLUTEN CHALLENGE METHOD
#202PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#203Process for assessing risk of substance administration
#204Method and kit for cytokine analysis from a human whole blood sample
#205METHODS OF TREATING IPEX SYNDROME USING TOXIN-BASED PHARMACEUTICAL COMPOSITIONS
#206Non-human animals having a humanized programmed cell death 1 gene
#207ELISPOT method having two filter systems
#208Cell mediated immune response assay
#209METHODS FOR MONITORING CD4+ T-HELPER TYPE 1 RESPONSE IN CANCER AND IMMUNE RESTORATION
#210Biomarkers in inflammatory bowel disease
#211COMPOSITIONS AND METHODS FOR DETECTION AND MODULATION OF T CELL MEDIATED IMMUNE RESPONSES AGAINST VIRAL VECTORS UTILIZED FOR GENE THERAPY
#212Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#213Method for diagnosing fibromyalgia
#214Peptide MHCII tetramers to detect endogenous calnexin specific CD4 T cells
#215CANCER DIAGNOSTIC AND THERAPEUTIC METHOD TARGETING MOLECULES EXPRESSED IN CANCER STEM CELLS
#216COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF MALIGNANT GLIOMAS
#217COMPOSITIONS AND METHODS FOR DETECTING, TREATING AND MONITORING ACTIVE BORRELIA INFECTION
#218Method for predicting the off-target biding of a peptide which binds to a target peptide presented by a major histocompatibility complex
#219ANTI-CANCER VACCINES
#220Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
#221USE OF POST-TRANSCRIPTIONAL GENE SILENCING FOR IDENTIFYING NUCLEIC ACID SEQUENCES THAT MODULATE THE FUNCTION OF A CELL
#222Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats
#223Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer
#224BIOMARKERS FOR DIAGNOSING AND/OR MONITORING TUBERCULOSIS
#225Diagnostic blood test for sarcoidosis
#226CANCER PROGNOSTIC ASSAYS
#227Status of Tuberculosis Infection in an Individual
#228Biomarkers
#229In-vitro process for the quick determination of a patient's status relating to infection with
#230Kit for monitoring immune status after transplant and method for monitoring immune status using same
#231Porous film microfluidic device for automatic surface plasmon resonance quantitative analysis
#232METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#233Whole brain lysate antigen-specific memory B cell and antibody assays in multiple sclerosis
#234Methods for diagnosing degenerative joint disease
#235EphA2 T-cell epitope agonists and uses therefore
#236Human exhaled aerosol droplet biomarker system and method
#237Methods for differentiating between disease states
#238Method for the diagnosis of and/or monitoring mucormycosis
#239Method for diagnosing Q-fever using a cellular immunological test
#240Engineered dendritic cells and uses for the treatment of cancer
#241Interferon-Gamma Response as a Diagnostic Test for Persistent Chlamydial Infections
#242PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#243STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#244Abrogating HIV-1 Infection via Drug-Induced Reactivation of Apoptosis
#245EphA2 T cell epitopes and uses therefor
#246NOVEL ASSAY FOR DETECTING IMMUNE RESPONSES INVOLVING ANTIGEN SPECIFIC CYTOKINE AND/OR ANTIGEN SPECIFIC CYTOKINE SECRETING T-CELLS
#247COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS
#248Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
#249Biomarker for treating cancer patients
#250Engineered Dendritic Cells and Uses for the Treatment of Cancer
#251Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#252Materials and methods for the treatment of celiac disease
#253BIOMARKER FOR MONITORING PATIENTS
#254Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#255Chitin-induced immune response based method for diagnosing allergic asthma in patients
#256Process for the measurement of the potency of glatiramer acetate
#257Methods and apparatus for conducting multiple measurements on a sample
#258CROSS-SPOT
#259PROTEINS EXPRESSED BY MYCOBACTERIUM TUBERCULOSIS AND NOT BY BCG AND THEIR USE AS VACCINES
#260ZAP-70 as predictor and modulator of effector function of T cells
#261STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#262Assay For Detecting Mycobacterial Infection
#263ELISPOT method having two filter systems
#264Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors
#265Cell-mediated immune response assay and kits therefor
#266Method of Diagnosis of Tuberculosis Related Immune Restoration Syndrome (IRS)
#267Nanoparticle and microparticle based detection of cellular products
#268ASSAYS TO PREDICT AND MONITOR ANTIBODY MEDIATED REJECTION OF TRANSPLANTED ALLOGRAFTS
#269Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy
#270Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#271Method for treating malignant melanoma
#272Clinical correlates
#273Engineered Dendritic Cells and Uses for the Treatment of Cancer
#274DIAGNOSTIC ASSAY FOR DETECTING AND MONITORING AGE RELATED AND NOISE INDUCED HEARING LOSS
#275Process for the measurement of the potency of glatiramer acetate
#276Methods to Treat or Prevent Viral-Associated Lymphoproliferative Disorders
#277Diagnostic test
#278Method for diagnosing and treating acute joint injury
#279Cd4+ Cd25+ T-cells activated to a specific antigen
#280Method for the detection of target molecules by fluorescence polarization using peptide mimics
#281EphA2 T-cell epitopes and uses therefor
#282Enhancement of Th2-Dependent and Inflammatory Response
#283METHODS AND COMPOSITIONS FOR ASSESSING IL-12 OR THE NEUTRALIZATION OF IL-12 IN A SAMPLE
#284Materials and methods for the treatment of celiac disease
#285Diagnostic method for paratuberculosis
#286METHODS FOR DIAGNOSING AND TREATING PAIN IN THE SPINAL CORD
#287Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#288Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#289Systems and methods for monitoring immune responses and predicting outcomes in transplant recipients
#290Modified mycobacterium tuberculosis strains and uses thereof
#291Novel IFNgamma-like polypeptides
#292EphA2 T-cell epitopes and uses therefor
#293Nanoparticle and microparticle based detection of cellular products
#294Method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
#295Method of detecting antigen-specific T lymphocytes
#296Novel complementing receptor-ligand pairs and adoptive immunotherapy using the same
#297EphA2 T-cell epitope agonists and uses therefor
#298Peptides for use in treatment and diagnosis of type 1 diabetes